Early Vascular Response 3 Months after Cobalt-chromium Everolimus-eluting Stent Implantation in Patients with Multivessel Coronary Artery Disease: Serial Angioscopic Observation Study

Abstract

Drug eluting stent (DES) remarkably reduced in-stent restenosis (ISR) compared with bare-metal stent. DES have developed from first generation to new generation DES, with improvement of stent technology, such as thinner strut stent, biocompatible polymer. Recent clinical studies have demonstrated better clinical outcome after new generation DES implantation compared with Early Vascular Response 3 Months after Cobalt-chromium Everolimus-eluting Stent Implantation in Patients with Multivessel Coronary Artery Disease: Serial Angioscopic Observation Study